SAPATNEKAR, A. Conventional Synthetic Disease-modifying Drugs Remain the Mainstay of Therapy for Rheumatoid Arthritis in India. Journal of the Diabetic Association of India, [S. l.], v. 1, n. 1, 2025. Disponível em: https://journals.onemd.in/index.php/jdai/article/view/59. Acesso em: 17 jul. 2025.